Diltiazem controlled release formulation and method of manufacture

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6524620
APP PUB NO 20010007681A1
SERIAL NO

09119323

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A controlled release diltiazem dosage formulation comprising a plurality of active pellets coated with an extended release coating wherein the active pellets contain diltiazem or a pharmaceutically acceptable salt, a pharmaceutically acceptable inert seed and a binder and the extended release coating contains a water insoluble water permeable polymer, a channeling agent, a lubricant and optionally a surfactant. A single batch intermittent method of manufacturing a heterogeneous population of extended release pellets for use as a dosage formulation is also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ANDRX PHARMACEUTICALS, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Chih-Ming Davie, FL 447 5446
Cheng, Xiu Xiu Davie, FL 39 845
Jan, Steve Coral Springs, FL 26 451

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation